MMRGlobal Awarded Another International Patent to Fight Cancer, Company Benefits From Worldwide HIT & Biotech Patents
LOS ANGELES, CA — (Marketwired) — 04/22/13 — (OTCQB: MMRF) ("MMR") today announced that the Australian Patent Office has issued a Notice of Allowance (NOA) for the Company-s anti-CD20 monoclonal antibody assets, #2007338607, under the title, "Antibodies and Methods for Making and Using Them." The patent application was originally filed on September 14, 2007. The Australian NOA is significant to the Company in that it reinforces the value of the U.S. antibody patent that